March 19, 2026
PRESS RELEASE

5th Soft Skills Workshop: The AI-Enhanced Scientist: Practical Use of Large Language Models in Research and Coding

Date and time: April 21st, 2026 | 11:00 AM- 1:00 PM

Format: online

Language: English

Speakers:

Michal Gala, Team Leader – Bioinformatics, MultiplexDX

Filip Németh, Bioinformatician, MultiplexDX

This workshop explores how modern AI and Large Language Models are transforming the way people work with information, generate ideas, and solve complex problems. Participants will gain an intuitive understanding of how these systems work, learn effective prompting techniques, and discover practical AI tools that can improve productivity across research.

Through practical examples, the session will demonstrate how AI can serve as a powerful assistant for tasks such as writing, coding, data exploration, and knowledge discovery - helping users turn AI into a reliable everyday collaborator rather than a mysterious black box.

Who Should Attend?​

  • Early-career and mid-career researchers​
  • PhD students and postdocs​
  • Academics and Researchers aiming to improve and redefine the use of AI and large language models in research workflows
  • Professionals in R&D interested in cross-sector perspectives

Key Takeaways:​

  • Understand how AI and LLMs work in practice
  • Learn effective prompting techniques
  • Use AI for writing, coding, and research tasks
  • Evaluate AI outputs critically
  • Integrate AI into everyday research workflows

We look forward to your participation!

The Soft Skills program is part of the ADDIT-CE project. The Czech-Slovak consortium and center of excellence aims to develop, validate, and implement modern and innovative diagnostics for Alzheimer's disease.

More info about the project

This event has received funding from the European Union’s Horizon Europe program under Grant Agreement No. 101087124. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.

If you have any questions: events@multiplexdx.com

About MultiplexDX

MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).

MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.

Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter

Other latest

MultiplexDX News